• AT Rated to Cortisporin®*
    Otic
    Suspension
  • 10 mL with sterilized dropper
     
  • Sterile Otic Suspension

Neomycin and Polymyxin B Sulfates and
Hydrocortisone Otic
Suspension, USP

Size Strength NDC
10mL with sterilized
dropper
3.5 mg (base)/mL,
10,000 units/mL,
10 mg/mL
0574-4103-10

 

 

Neomycin and Polymyxin B Sulfates and Hydrocortisone Otic Suspension, USP is a Sterile Antibacterial and Anti-Inflammatory Suspension for otic use.

Indicated for the treatment of superficial bacterial infections of the external auditory canal caused by organisms susceptible to the action of the antibiotics, and for the treatment of infections of mastoidectomy and fenestration cavities caused by organisms susceptible to the antibiotics. This product is contraindicated in persons who have shown hypersensitivity to any of its components, and in herpes simplex, vaccinia and varicella infections. Warnings: Neomycin can induce permanent sensorineural hearing loss due to cochlear damage, mainly destruction of hair cells in the organ of Corti. The risk is greater with prolonged use. Therapy should be limited to 10 consecutive days. Patients being treated with eardrops containing neomycin should be under close clinical observation. Neomycin and Polymyxin B Sulfates and Hydrocortisone Otic Suspension, USP should not be used in any patient with a perforated tympanic membrane.

Discontinue promptly if sensitization or irritation occurs.

Neomycin sulfate may cause cutaneous sensitization. A precise incidence of hypersensitivity reactions (primarily skin rash) due to topical neomycin is not known.

When using neomycin-containing products to control secondary infection in the chronic dermatoses, such as chronic otitis externa or stasis dermatitis, it should be borne in mind that the skin in these conditions is more liable than is normal skin to become sensitized to many substances, including neomycin. The manifestation of sensitization to neomycin is usually a low-grade reddening with swelling, dry scaling, and itching; it may be manifest simply as a failure to heal. Periodic examination for such signs is advisable, and the patient should be told to discontinue the product if they are observed. These symptoms regress quickly on withdrawing the medication. Neomycin-containing applications should be avoided for the patient thereafter.

For additional information, see prescribing info link below.

For wholesaler stocking numbers contact Paddock Customer Relations.

Read the Material Safety Data Sheet
Read the Neomycin  and Polymyxin B Sulfates and 
     Hydrocortisone Otic Suspension, USP
Prescribing Info


To read and print the data sheets, you will need to have Adobe Acrobat Reader installed on your computer. You can download a free copy by clicking on the following image.

*Cortisporin® is a registered trademark of Monarch Pharmaceuticals, Inc

 

PADDOCK NEWS
Paddock Receives HDMA DIANA Award


Paddock Laboratories Pharmacy Education Center Now Open

Paddock Appoints
New President and CEO

Paddock Donates
$2 Million: U of M
Pharmacy Program

Buy Glutose Online

Secundum Artem
Now available in PDF form.

Company Profile:
Video now available

NEW PRODUCTS
Neomycin & Polymyxin B Sulfates & Gramicidin Ophthalmic Solution, USP

AT Rated Generic Alternative

Neomycin & Polymyxin B Sulfates & Hydrocortisone Otic Solution, USP
AT Rated Generic Alternative

Testosterone Cypionate Injection, USP 200 mg/mL CIII
AO Rated to Depo®-Testosterone

Ciclopirox Gel, 0.77%
First Generic Now Available

Testosterone Enanthate Injection USP 200 mg
/mL CIII
AO Rated to Delatestryl®

 

©2007 All Rights Reserved. Sales Policy.
Paddock Laboratories, Inc., 3940 Quebec Avenue No., Mpls., MN 55427

Hit Counter